Giving contamination time to build up can cause headaches for more than just your company.
This article was also published in our US sister publication Pharmaceutical Technology and can be read here.
Ingredients Insider Cynthia ChallenerFDA Steps Up Foreign Inspections
The past six months has seen some major changes to the sterile manufacturing landscape in Europe. There have been a number of exits and acquisitions that have no doubt grabbed headlines, but has anything really changed?
Cornell Stamoran, Catalent Pharma Solutions vice-president, is elected to the board of trustees of the Pharma & Biopharma Outsourcing Association.